Designed to help address industry challenges and provide comprehensive solutions, A&M’s Life Sciences Business Unit leverages the firm’s integrated platform and represents its next capabilities milestone for delivering inventive solutions and driving sustainable growth.

In today’s market, Pharma, Biotech, and MedTech companies must continue to seek organic and inorganic opportunities to drive growth. Our team of experienced and action-oriented professionals address the broad needs of your enterprise - from transactions and transformation to optimization activities.
Many of the miracles of modern science have been developed right in your laboratories, extending both the length and quality of lives around the world. But extreme market pressures — from the loss of patent protection and the rise of generic and counterfeit products to the downward pricing pressures exerted by governments and evolving healthcare systems — challenge you and your industry. A&M’s top-line professionals have the proven strategies to remedy these issues.
A&M’s EMEA Healthcare & Life Sciences (HLS) practice offers a “bias-to-action” approach through a unique blend of seasoned industry operational executives and world-class advisory experience.
FOLLOW & CONNECT WITH A&M